This technology gives for example the opportunity to effectively enhance certain pharmaceutical production processes that use biosynthesis of bacteria or yeast, by selectively cultivating and optimizing only the best fitting individuals.
A European and a US patent application have been filed for this invention (WO2012/152844A2).
Advantages of this technology have been shown in several experiments and further information can be given on request. A third generation prototype has recently been developed, which is optimised regarding durability, functionality and manufacturing costs.
PROvendis is offering licenses for this technology to interested companies on behalf of the TU Dortmund University.